Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Engineering cancer resistance in mice.

Klatt P, Serrano M.

Carcinogenesis. 2003 May;24(5):817-26. Review.

PMID:
12771024
2.

Mouse models of lung cancer.

Dutt A, Wong KK.

Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4396s-4402s. Review.

3.

[Application and recent advances of laboratory mouse in human cancer research].

Liu EQ, Kitajima S, Morimoto M.

Ai Zheng. 2005 Feb;24(2):249-54. Review. Chinese.

PMID:
15694046
4.

Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.

Ishii K, Shappell SB, Matusik RJ, Hayward SW.

Lab Invest. 2005 Sep;85(9):1086-103.

5.

Interpretation of phenotype in genetically engineered mice.

Doetschman T.

Lab Anim Sci. 1999 Apr;49(2):137-43. Review.

PMID:
10331542
6.

A mouse model of oral-esophageal carcinogenesis.

Opitz OG, Quante M, von Werder A, Heeg S, Blum HE.

Onkologie. 2005 Jan;28(1):44-8.

PMID:
15696643
7.

Viewpoint: are studies in genetically altered mice out of control?

Sigmund CD.

Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1425-9. Review.

8.

[Molecular models of disease. Transgenes and knockout].

Moradpour D.

Dtsch Med Wochenschr. 1997 Dec 5;122(49):1527-30. German. No abstract available.

PMID:
9453919
9.

Future of early detection of lung cancer: the role of mouse models.

Shaw AT, Kirsch DG, Jacks T.

Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):4999s-5003s. Review.

10.

Mouse models for multistep tumorigenesis.

Wu X, Pandolfi PP.

Trends Cell Biol. 2001 Nov;11(11):S2-9. Review.

PMID:
11684435
11.

Genetically modified mice in cancer research.

Largaespada DA.

Methods Mol Biol. 2003;209:311-32. Review. No abstract available.

PMID:
12357959
12.

Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD.

Cancer Res. 2004 Mar 15;64(6):2270-305. Review.

13.

[Genetically engineered mice and its application to bioindustry].

Koda T, Togashi Y, Nishimura T.

Hokkaido Igaku Zasshi. 2002 Mar;77(2):151-6. Review. Japanese.

PMID:
11968850
14.

Cardiovascular and renal phenotyping of genetically modified mice: a challenge for traditional physiology.

Fitzgerald SM, Gan L, Wickman A, Bergström G.

Clin Exp Pharmacol Physiol. 2003 Apr;30(4):207-16. Review.

PMID:
12680837
15.
16.

Mice mutant for genes associated with schizophrenia: common phenotype or distinct endophenotypes?

Desbonnet L, Waddington JL, Tuathaigh CM.

Behav Brain Res. 2009 Dec 7;204(2):258-73. Review.

PMID:
19728400
17.

Technologically advanced cancer modeling in mice.

Tuveson DA, Jacks T.

Curr Opin Genet Dev. 2002 Feb;12(1):105-10. Review.

PMID:
11790563
18.

Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic.

Mossbrugger I, Hoelzlwimmer G, Calzada-Wack J, Quintanilla-Martinez L.

Verh Dtsch Ges Pathol. 2007;91:98-103.

PMID:
18314602
19.

Building 'validated' mouse models of human cancer.

Hann B, Balmain A.

Curr Opin Cell Biol. 2001 Dec;13(6):778-84. Review.

PMID:
11698196
20.

Applications of transgenic and knockout mice in alcohol research.

Bowers BJ.

Alcohol Res Health. 2000;24(3):175-84. Review.

Supplemental Content

Support Center